Monitoring participants’ mental health during clinical trials is crucial in ensuring their safety and well-being. Tools like the Columbia–Suicide Severity Rating Scale (C-SSRS) play a vital role in this process.
The C-SSRS provides a standardized method to assess the severity and risk of suicidal thoughts and behaviors, allowing researchers to identify participants who may need immediate intervention.
Regular mental health monitoring helps to prevent adverse events, supports ethical study conduct, and ensures the reliability of trial outcomes by maintaining the overall health of the participants.